The Emerging Role of MORC Family Proteins in Cancer Development and Bone Homeostasis

Journal of Cellular Physiology

Volumn 232, Issue 5, 2017, Pages 928-934

  Hong, Guoju ^a,b   Qiu, Heng ^b   Wang, Chao ^b   Jadhav, Gaurav ^b   Wang, Haibin ^a   Tickner, Jennifer ^b   He, Wei ^a   Xu, Jiake ^a,b  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORCHIDIA 1 PROTEIN; MICRORCHIDIA 2 PROTEIN; MICRORCHIDIA 3 PROTEIN; MICRORCHIDIA 4 PROTEIN; MICRORCHIDIA PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; NUCLEAR PROTEIN;

ARTICLE; BONE METABOLISM; CARCINOGENESIS; CHEMICAL STRUCTURE; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; BONE; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; HOMEOSTASIS; METABOLISM; NEOPLASM;

AMINO ACID SEQUENCE; ANIMALS; BONE AND BONES; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMANS; NEOPLASMS; NUCLEAR PROTEINS;

EID: 85006132056     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25665     Document Type: Article

References (54)

1. Aghdassi AA, Weiss FU, Mayerle J, Lerch MM, Simon P. 2015. Genetic susceptibility factors for alcohol-induced chronic pancreatitis. Pancreatology 15:S23–S31.
2. Bicocca VT, Chang BH, Masouleh BK, Muschen M, Loriaux MM, Druker BJ, Tyner JW. 2012. Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. Cancer Cell 22:656–667.
3. Ceribelli A, Fredi M, Taraborelli M, Cavazzana I, Franceschini F, Quinzanini M, Tincani A, Ross SJ, Chan JY, Pauley BA, Chan EK, Satoh M. 2012. Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. Arthritis Res Ther 14:R97.
4. Chen LH, Kuo WH, Tsai MH, Chen PC, Hsiao CK, Chuang EY, Chang LY, Hsieh FJ, Lai LC, Chang KJ. 2011. Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan. PLoS ONE 6:e28222.
5. Condomines M, Hose D, Hundemer M, Vos JD, Baudard M, Moehler T, Pantesco V, Moos M, Schved JF, Rossi JF, Rème T, Goldschmidt H, Klein B. 2007. Cancer/testis genes in multiple myeloma: Expression patterns and prognosis value determined by microarray analysis. J Immunol 178:3307–3315.
6. Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM, Ferec C, Drenth JP, Witt H, Rosendahl J, PanEuropean Working group on Alcoholic Chronic Pancreatitis M, Collaborators. 2015. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut 64:1426–1433.
7. Fujimoto N, Takayama S, Hamaguchi Y, Fujimoto M, Tanaka T. 2014. Pemphigus foliaceus associated with anti-NXP2 autoantibody-positive dermatomyositis. Acta Derm Venereol 94:478–479.
8. Giri AK, Midha S, Banerjee P, Agrawal A, Mehdi SJ, Dhingra R, Kaur I, G RK, Lakhotia R, Ghosh S, Das K, Mohindra S, Rana S, Bhasin DK, Garg PK, Bharadwaj D, Indipan, Consortium I. 2016. Common variants in CLDN2 and MORC4 genes confer disease susceptibility in patients with chronic pancreatitis. PLoS ONE 11:e0147345.
9. Glennon NB, Jabado O, Lo MK, Shaw ML. 2015. Transcriptome profiling of the virus-induced innate immune response in pteropus vampyrus and its attenuation by nipah virus interferon antagonist functions. J Virol 89:7550–7566.
10. Gonzalez-Fernandez R, Morales M, Avila J, Martin-Vasallo P. 2012. Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy. Oncol Lett 3:1341–1349.
11. Guex N, Peitsch MC. 1997. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18:2714–2723.
12. Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group UK, Ireland. 2009. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807–1814.
13. He F, Umehara T, Saito K, Harada T, Watanabe S, Yabuki T, Kigawa T, Takahashi M, Kuwasako K, Tsuda K, Matsuda T, Aoki M, Seki E, Kobayashi N, Guntert P, Yokoyama S, Muto Y. 2010. Structural insight into the zinc finger CW domain as a histone modification reader. Structure 18:1127–1139.
14. Ichimura Y, Matsushita T, Hamaguchi Y, Kaji K, Hasegawa M, Tanino Y, Inokoshi Y, Kawai K, Kanekura T, Habuchi M, Igarashi A, Sogame R, Hashimoto T, Koga T, Nishino A, Ishiguro N, Sugimoto N, Aoki R, Ando N, Abe T, Kanda T, Kuwana M, Takehara K, Fujimoto M. 2012. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: Possible association with malignancy. Ann Rheum Dis 71:710–713.
15. Inoue N, Hess KD, Moreadith RW, Richardson LL, Handel MA, Watson ML, Zinn AR. 1999. New gene family defined by MORC, a nuclear protein required for mouse spermatogenesis. Hum Mol Genet 8:1201–1207.
16. Iyer LM, Abhiman S, Aravind L. 2008. MutL homologs in restriction-modification systems and the origin of eukaryotic MORC ATPases. Biol Direct 3:8.
17. Jadhav G, Teguh D, Kenny J, Tickner J, Xu J. 2016. Morc3 mutant mice exhibit reduced cortical area and thickness, accompanied by altered haematopoietic stem cells niche and bone cell differentiation. Sci Rep 6:25964.
18. Kimura Y, Sakai F, Nakano O, Kisaki O, Sugimoto H, Sawamura T, Sadano H, Osumi T. 2002. The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains. J Biol Chem 277:20611–20617.
19. Kolosa K, Motaln H, Herold-Mende C, Korsic M, Lah TT. 2015. Paracrine effects of mesenchymal stem cells induce senescence and differentiation of glioblastoma stem-like cells. Cell Transplant 24:631–644.
20. Koslowski M, Tureci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U. 2002. Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Cancer Res 62:6750–6755.
21. Li DQ, Nair SS, Kumar R. 2013. The MORC family: New epigenetic regulators of transcription and DNA damage response. Epigenetics 8:685–693.
22. Li DQ, Nair SS, Ohshiro K, Kumar A, Nair VS, Pakala SB, Reddy SD, Gajula RP, Eswaran J, Aravind L, Kumar R. 2012a. MORC2 signaling integrates phosphorylation-dependent, ATPase-coupled chromatin remodeling during the DNA damage response. Cell Rep 2:1657–1669.
23. Li X, Foley EA, Molloy KR, Li Y, Chait BT, Kapoor TM. 2012b. Quantitative chemical proteomics approach to identify post-translational modification-mediated protein-protein interactions. J Am Chem Soc 134:1982–1985.
24. Liggins AP, Cooper CD, Lawrie CH, Brown PJ, Collins GP, Hatton CS, Pulford K, Banham AH. 2007. MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas. Br J Haematol 138:479–486.
25. Ling KH, Hewitt CA, Tan KL, Cheah PS, Vidyadaran S, Lai MI, Lee HC, Simpson K, Hyde L, Pritchard MA, Smyth GK, Thomas T, Scott HS. 2014. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks. BMC Genomics 15:624.
26. Ma J, Zhang T, Novotny-Diermayr V, Tan AL, Cao X. 2003. A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation. J Biol Chem 278:29252–29260.
27. Mimura Y, Takahashi K, Kawata K, Akazawa T, Inoue N. 2010. Two-step colocalization of MORC3 with PML nuclear bodies. J Cell Sci 123:2014–2024.
28. Moissiard G, Cokus SJ, Cary J, Feng S, Billi AC, Stroud H, Husmann D, Zhan Y, Lajoie BR, McCord RP, Hale CJ, Feng W, Michaels SD, Frand AR, Pellegrini M, Dekker J, Kim JK, Jacobsen SE. 2012. MORC family ATPases required for heterochromatin condensation and gene silencing. Science 336:1448–1451.
29. Nagase T, Seki N, Tanaka A, Ishikawa K, Nomura N. 1995. Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res 2:167–174, 199–210.
30. Paliwal S, Bhaskar S, Reddy DN, Rao GV, Thomas V, Singh SP, Chandak GR. 2016. Association analysis of PRSS1-PRSS2 and CLDN2-MORC4 variants in nonalcoholic chronic pancreatitis using tropical calcific pancreatitis as model. Pancreas 45:1153–1157.
31. Pastor WA, Stroud H, Nee K, Liu W, Pezic D, Manakov S, Lee SA, Moissiard G, Zamudio N, Bourc'his D, Aravin AA, Clark AT, Jacobsen SE. 2014. MORC1 represses transposable elements in the mouse male germline. Nat Commun 5:5795.
32. Perry J, Zhao Y. 2003. The CW domain, a structural module shared amongst vertebrates, vertebrate-infecting parasites and higher plants. Trends Biochem Sci 28:576–580.
33. Raveau M, Lignon JM, Nalesso V, Duchon A, Groner Y, Sharp AJ, Dembele D, Brault V, Herault Y. 2012. The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model. PLoS Genet 8:e1002724.
34. Rosendorff A, Sakakibara S, Lu S, Kieff E, Xuan Y, DiBacco A, Shi Y, Gill G. 2006. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc Natl Acad Sci U S A 103:5308–5313.
35. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: A unified platform for automated protein structure and function prediction. Nat Protoc 5:725–738.
36. Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, Calzada-Wack J, Cohrs CM, Klaften M, Seedorf H, Eck S, Benet-Pages A, Favor J, Esposito I, Strom TM, Wolf E, Lorenz-Depiereux B, Hrabe de Angelis M. 2012. New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis. Mamm Genome 23:416–430.
37. Sanchez-Solana B, Li DQ, Kumar R. 2014. Cytosolic functions of MORC2 in lipogenesis and adipogenesis. Biochim Biophys Acta 1843:316–326.
38. Schmidt M, Brandwein C, Luoni A, Sandrini P, Calzoni T, Deuschle M, Cirulli F, Riva MA, Gass P. 2016. Morc1 knockout evokes a depression-like phenotype in mice. Behav Brain Res 296:7–14.
39. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, Steidl C, Holt RA, Jones S, Sun M, Leung G, Moore R, Severson T, Taylor GA, Teschendorff AE, Tse K, Turashvili G, Varhol R, Warren RL, Watson P, Zhao Y, Caldas C, Huntsman D, Hirst M, Marra MA, Aparicio S. 2009. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461:809–813.
40. Shao Y, Li Y, Zhang J, Liu D, Liu F, Zhao Y, Shen T, Li F. 2010. Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX. Nucleic Acids Res 38:2813–2824.
41. Soderman J, Noren E, Christiansson M, Bragde H, Thiebaut R, Hugot JP, Tysk C, O'Morain CA, Gassull M, Finkel Y, Colombel JF, Lemann M, Almer S. 2013. Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease. World J Gastroenterol 19:4935–4943.
42. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101:6062–6067.
43. Takahashi K, Yoshida N, Murakami N, Kawata K, Ishizaki H, Tanaka-Okamoto M, Miyoshi J, Zinn AR, Shime H, Inoue N. 2007. Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell 18:1701–1709.
44. Tong Y, Li Y, Gu H, Wang C, Liu F, Shao Y, Li J, Cao L, Li F. 2015. Microchidia protein 2, MORC2, downregulates the cytoskeleton adapter protein, ArgBP2, via histone methylation in gastric cancer cells. Biochem Biophys Res Commun 467:821–827.
45. Tuupanen S, Hanninen UA, Kondelin J, von Nandelstadh P, Cajuso T, Gylfe AE, Katainen R, Tanskanen T, Ristolainen H, Bohm J, Mecklin JP, Jarvinen H, Renkonen-Sinisalo L, Andersen CL, Taipale M, Taipale J, Vahteristo P, Lehti K, Pitkanen E, Aaltonen LA. 2014. Identification of 33 candidate oncogenes by screening for base-specific mutations. Br J Cancer 111:1657–1662.
46. Urganus AL, Zhao YD, Pachman LM. 2009. Juvenile dermatomyositis calcifications selectively displayed markers of bone formation. Arthritis Rheum 61:501–508.
47. Ver LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, Ortin J. 2015. The cellular factor NXP2/MORC3 is a positive regulator of influenza virus multiplication. J Virol 89:10023–10030.
48. Wang GL, Song YY, Liu T, Wang CY, Zhang Q, Liu FR, Cai XZ, Miao ZF, Xu HD, Cao L, Li F. 2015. PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis. Oncotarget 6:9877–9886.
49. Wang GL, Wang CY, Cai XZ, Chen W, Wang XH, Li F. 2010. Identification and expression analysis of a novel CW-type zinc finger protein MORC2 in cancer cells. Anat Rec (Hoboken) 293:1002–1009.
50. Watson ML, Zinn AR, Inoue N, Hess KD, Cobb J, Handel MA, Halaban R, Duchene CC, Albright GM, Moreadith RW. 1998. Identification of morc (microrchidia), a mutation that results in arrest of spermatogenesis at an early meiotic stage in the mouse. Proc Natl Acad Sci U S A 95:14361–14366.
51. Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. 2015. The I-TASSER suite: Protein structure and function prediction. Nat Methods 12:7–8.
52. Yang K, Zhu J, Sun S, Tang Y, Zhang B, Diao L, Wang C. 2004. The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination. Biochem Biophys Res Commun 324:432–439.
53. Zhang Q, Song YY, Chen W, Wang XH, Miao ZF, Cao L, Li F, Wang GL. 2015. By recruiting HDAC1, MORC2 suppresses p21Waf1/Cip1 in gastric cancer. Oncotarget 6:16461–16470.
54. Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40.